Managing Editor – Europe
Latest From Tom Gallen
Australian-heritage supplements brand Swisse has secured the rights to use ChromaDex' patented Niagen ingredient - marketed to help consumers "age better" - in a new product range.
Genomma Lab reports OTC sales rise in Q1 thanks to gains in its LATAM region, while Brazil's Hypera posts big jump in turnover due to acquisitions.
Medice has expanded its consumer health offering by taking a 60% stake in German herbal medicines specialist Schaper & Brümmer.
Nestlé is poised to add to its Health Science portfolio the Nature's Bounty, Solgar, Osteo Bi-Flex and Puritan’s Pride dietary supplement brands, which generate the majority of their sales in the North American market.
The European Commission has approved a health claim related to carbohydrate solutions used in sports drinks after receiving a positive opinion from EFSA.
Reckitt reports major drop in OTC sales in Q1 as the cold and flu season was almost wiped out by social distancing measures related to COVID-19. CEO Laxman Narasimhan reveals he has seen green shoots in certain markets where restrictions have started to relax, insisting "there is no question flu will come back."